Compared to U87-control, U87-3 mM NaDCA, and U87-2 mM VPA–3 mM NaDCA tumors, there were no significant differences in PCNA expression, and treatment with 50 μM TMZ significantly reduced the number of PCNA-positive cells in the U87 tumor. The gene discussed is PCNA; the disease is neoplasm.